Abstract
The different factors involved as etiological agents in thyroid cancer have in common long term thyroid follicle stimulation. On this base, a patient with a TSH-producing pituitary adenoma could be at high risk for developing thyroid cancer. A patient consulting for a single thyroid nodule was studied in our unit. He was diagnosed as having a TSH-producing pituitary adenoma and the Thyroid nodule was shown to be a follicular carcinoma following removed. We speculate that elevated TSH levels could have contributed to neoplastic transformation of the thyroid in this patient.
MeSH terms
-
Adenocarcinoma / complications*
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / metabolism
-
Adenocarcinoma / pathology
-
Adenoma / complications*
-
Adenoma / pathology
-
Brain / diagnostic imaging
-
Carbidopa / therapeutic use
-
Drug Therapy, Combination
-
Growth Hormone / pharmacology
-
Growth Hormone-Releasing Hormone / pharmacology
-
Humans
-
Hydrocortisone / therapeutic use
-
Insulin / pharmacology
-
Levodopa / therapeutic use
-
Male
-
Middle Aged
-
Pituitary Neoplasms / complications*
-
Pituitary Neoplasms / drug therapy
-
Pituitary Neoplasms / metabolism
-
Pituitary Neoplasms / pathology
-
Prolactin / blood
-
Radioimmunoassay
-
Thyroid Neoplasms / complications*
-
Thyroid Neoplasms / drug therapy
-
Thyroid Neoplasms / metabolism
-
Thyroid Neoplasms / pathology
-
Thyrotropin / blood
-
Thyrotropin-Releasing Hormone / pharmacology
-
Thyroxine / blood
-
Thyroxine / therapeutic use
-
Tomography, X-Ray Computed
-
Triiodothyronine / blood
Substances
-
Insulin
-
Triiodothyronine
-
Levodopa
-
Thyrotropin-Releasing Hormone
-
Prolactin
-
Thyrotropin
-
Growth Hormone
-
Growth Hormone-Releasing Hormone
-
Carbidopa
-
Thyroxine
-
Hydrocortisone